Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 3/2010

01.05.2010

The Quality-of-Life Impact of Prostate Cancer Treatments

verfasst von: Jaspreet Singh, Edouard J. Trabulsi, Leonard G. Gomella

Erschienen in: Current Urology Reports | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Many options exist for the treatment of localized prostate cancer. In the decision to choose a therapeutic option for localized disease, many variables need to be considered such as tumor characteristics, clinical stage, the patient’s overall health and life expectancy, and preferences of both the physician and patient. Another important consideration is the health-related quality of life (HRQOL) implications of a given treatment option. The importance of HRQOL relative to the potential side effects of prostate cancer treatments has grown over the past few years. Although our collective awareness has increased, objective data on HRQOL for prostate cancer treatment are lacking due to a paucity of prospective clinical trial data. This review defines the concept of HRQOL, discusses what is currently known about the impact of various treatments on HRQOL, and summarizes the recent literature in this area relating to the management of localized prostate cancer.
Literatur
1.
Moul JW, Mouraviev V, Sun L, et al.: Prostate cancer: the new landscape. Curr Opin Urol 2009, 19:154–160.CrossRefPubMed
2.
Moore AL, Dimitropoulou R, Lane A, et al.: Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU 2009, 104:1592–1598.CrossRef
3.
Jang TL, Yossepowitch O, Bianco F, Scardino PT: Low risk prostate cancer in men under age 65: the case for definitive treatment. Urol Oncol 2007, 25:510–514.PubMed
4.
Quek M, Penson D: Quality of life instruments in prostate cancer. In Treatment Methods for Early and Advanced Prostate Cancer, edn 1. Edited by Kirby RS, Feneley M. London, Informa Healthcare; 2008:41–44.
5.
Meyer KB, Clayton KA: Measurement and analysis of patient-reported outcomes. Clin Epidemiol 2008, 473:1–15.CrossRef
6.
van Andel G, Bottomley A, Fossa SD, et al.: An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008, 44:2418–2424.CrossRefPubMed
7.
van den Bergh RC, Essink-Bot ML, Roobol MJ, et al.: Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009, 115:3868–3878.CrossRefPubMed
8.
Burnet KL, Parker C, Dearnaley D, et al.: Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int 2007, 100:540–543.CrossRefPubMed
9.
10.
Bellizzi KM, Latini DM, Cowan JE, et al.: Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology 2008, 72:1269–1273.CrossRefPubMed
11.
•• Sanda MG, Dunn RL, Michalski J, et al.: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250–1261. This article evaluated HRQOL domains among patients and their partners in each prostate cancer treatment modality.
12.
Gacci M, Simonato A, Masieri L, et al.: Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. Health Qual Life Outcomes 2009, 13:94.CrossRef
13.
•• Chen RC, Clark JA, Talcott JA: Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol 2009, 27:3916–3922. This article discusses HRQOL treatment–related complications stratified by baseline categories for sexual, bowel, and urinary function.
14.
Coelho RF, Chauhan S, Palmer KJ, et al.: Robotic-assisted radical prostatectomy: a review of current outcomes. BJU Int 2009, 104:1428–1435.CrossRefPubMed
15.
• Hu JC, Gu X, Lipsitz SR, et al.: Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009, 302:1557–1564. Men undergoing minimally invasive versus open prostatectomy RRP experienced more genitourinary complications, incontinence, and erectile dysfunction at the expense of shorter length of stay, and fewer surgical complications.
16.
Abel EJ, Masterson TA, Warner JN, et al.: Nerve-sparing prostatectomy and urinary function: a prospective analysis using validated quality-of-life measures. Urology 2009, 73:1336–1340.CrossRefPubMed
17.
Nandipati KC, Raina R, Agarwal A, Zippe CD: Nerve-sparing surgery significantly affects long-term continence after radical prostatectomy. Urology 2007, 70:1127–1130.CrossRefPubMed
18.
Roeloffzen EMA, Hinnen KA, Battermann JJ, et al.: The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life. Int J Radiat Oncol Biol Phys 2009 Nov 23 (Epub ahead of print).
19.
Pinkawa M, Fischedick K, Asadpour B, et al.: Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer: a prospective analysis. Radiother Oncol 2008, 88:135–139.CrossRefPubMed
20.
• Sonn GA, Sadetsky N, Presti JC, Litwin MS: Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol 2009 182:2296–2302. Physician ratings of patients’ symptoms do not correlate well with patient self-assessments of HRQOL.
21.
Carlsson S, Aus G, Wessman C, et al.: Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA)—results from a prospective, population-based, randomised study. Eur J Cancer 2007, 43:2109–2116.CrossRefPubMed
22.
Katz DA, Jarrard DF, McHorney CA, et al.: Health perceptions in patients who undergo screening and workup for prostate cancer. Urology 2007, 69:215–220.CrossRefPubMed
23.
Love AW, Scealy M, Bloch S, et al.: Psychosocial adjustment in newly diagnosed prostate cancer. Aust N Z J Psychiatry 2008, 42:423–429.CrossRefPubMed
24.
Reeve BB, Potosky AL, Smith AW, et al.: Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst 2009, 101:860–868.CrossRefPubMed
25.
Gacci M, Lapini A, Serni S, et al.: Predictors of quality of life after radical treatment for prostate cancer. Urol Int 2008, 80:231–236.CrossRefPubMed
26.
Gupta D, Granick J, Grutsch JF, Lis CG: The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer 2007, 15:387–393.CrossRefPubMed
27.
Sadetsky N, Hubbard A, Carroll PR, et al.: Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res 2009, 18:1019–1027.CrossRefPubMed
28.
Northouse LL, Mood DW, Montie JE, et al.: Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol 2007, 25:4171–4177.CrossRefPubMed
29.
Badr H, Taylor CL: Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 2009, 18:735–746.CrossRefPubMed
30.
Northouse LL, Mood DW, Schafenacker A, et al.: Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer 2007, 110:2809–2818.CrossRefPubMed
31.
Harden J, Falahee, M, Bickes J, et al.: Factors associated with prostate cancer patients’ and their spouses’ satisfaction with a family-based intervention conclusion. Cancer Nurs 2009, 32:482–492.CrossRefPubMed
32.
Jayadevappa R, Johnson JC, Chhatre SE, et al.: Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer 2007, 109:2229–2238.CrossRefPubMed
33.
Do YK, Carpenter WR, Spain P, et al.: Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control 2010, 21:21–40.CrossRef
34.
Hinz A, Krauss O, Hauss JP, et al.: Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care 2009 (in press).
Metadaten
Titel
The Quality-of-Life Impact of Prostate Cancer Treatments
verfasst von
Jaspreet Singh
Edouard J. Trabulsi
Leonard G. Gomella
Publikationsdatum
01.05.2010
Verlag
Current Science Inc.
Erschienen in
Current Urology Reports / Ausgabe 3/2010
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-010-0103-y

Weitere Artikel der Ausgabe 3/2010

Current Urology Reports 3/2010 Zur Ausgabe

ReviewPaper

Focal Cryotherapy for Prostate Cancer

ReviewPaper

Technological Advances in Radiation Therapy for Prostate Cancer

ReviewPaper

Active Surveillance for Prostate Cancer: A Review

ReviewPaper

A Review of Methods for Hemostasis and Renorrhaphy After Laparoscopic and Robot-assisted Laparoscopic Partial Nephrectomy

ReviewPaper

Prostate Cancer Screening: What We Have Learned from the PLCO and ERSPC Trials

ReviewPaper

Factors Predicting Early Return of Continence After Radical Prostatectomy

Neu im Fachgebiet Urologie

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise